0
3 Horrendous Health-Care
Stocks This Week
It’s been a horrible week
for many health-care
stocks. A few, though, had
particularly bad rides. Here
are the week’s most...
The biotech’s shares plunged over 28% for the week.
Puma Biotechnology (NYSE: PBYI)
Source: Yahoo! Finance
• Puma announced results from a mid-
stage study of neratinib in treating
breast cancer.
• The results disappointed invest...
Shares of the biopharmaceutical company focusing on pet
medications dropped nearly 23% this week.
Kindred Biosciences (Nas...
• Kindred announced a secondary
offering of 3.45 million shares at $18 on
Tuesday with little effect on the stock
price.
•...
The stock of the cloud-based healthcare technology company fell
nearly 21% this week.
Castlight Health (NYSE: CSLT)
Source...
• After a big IPO pop in March, Castlight
has felt the sting of critics in recent
weeks.
• Castlight is the “most overpric...
• Any of this week’s horrendous stocks
could rebound, but Puma
Biotechnology gets the nod as most
likely to bounce back.
•...
Find out which stock The Motley Fool’s chief
investment officer selected as the top pick for
2014 in our free report!
Upcoming SlideShare
Loading in...5
×

3 horrendous healthcare stocks this week 4-11-14

4,130

Published on

This week's worst healthcare stocks

1 Comment
2 Likes
Statistics
Notes
No Downloads
Views
Total Views
4,130
On Slideshare
0
From Embeds
0
Number of Embeds
9
Actions
Shares
0
Downloads
12
Comments
1
Likes
2
Embeds 0
No embeds

No notes for slide
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-affymetrix-inc-shares-dropped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • http://www.fool.com/investing/general/2014/02/06/why-medidata-solutions-inc-shares-dipped.aspx
  • Transcript of "3 horrendous healthcare stocks this week 4-11-14"

    1. 1. 3 Horrendous Health-Care Stocks This Week
    2. 2. It’s been a horrible week for many health-care stocks. A few, though, had particularly bad rides. Here are the week’s most horrendous health-care stocks of all.
    3. 3. The biotech’s shares plunged over 28% for the week. Puma Biotechnology (NYSE: PBYI) Source: Yahoo! Finance
    4. 4. • Puma announced results from a mid- stage study of neratinib in treating breast cancer. • The results disappointed investors because the benefits weren’t as positive as hoped. • 39% of patients developed moderate to severe diarrhea, prompting Puma to add higher doses of an anti- diarrheal drug to other studies of neratinib. Why Puma’s shares got pummeled
    5. 5. Shares of the biopharmaceutical company focusing on pet medications dropped nearly 23% this week. Kindred Biosciences (NasdaqOTH: KIN) Source: Yahoo! Finance
    6. 6. • Kindred announced a secondary offering of 3.45 million shares at $18 on Tuesday with little effect on the stock price. • The company presented at the Needham conference on Wednesday – again with shares not moving much. • Thursday saw a huge drop with the big overall biotech plunge. • The stock continued a steady sell-off that started over three weeks ago. Why Kindred shares crashed
    7. 7. The stock of the cloud-based healthcare technology company fell nearly 21% this week. Castlight Health (NYSE: CSLT) Source: Yahoo! Finance
    8. 8. • After a big IPO pop in March, Castlight has felt the sting of critics in recent weeks. • Castlight is the “most overpriced IPO of the century,” according to Yahoo! Finance. • The overall pullback in technology stocks seems to be sweeping Castlight in its path, but at an even faster rate of decline -- probably because of those perceptions that the stock is priced too highly. Why Castlight dimmed
    9. 9. • Any of this week’s horrendous stocks could rebound, but Puma Biotechnology gets the nod as most likely to bounce back. • The market reaction to Puma’s neratinib results seems somewhat overdone -- there’s still a good chance that the drug will perform well in phase 3 studies. • As investors digest the latest results more (and the general biotech sell-off ultimately wanes), Puma could mount a comeback. Best shot at bouncing back?
    10. 10. Find out which stock The Motley Fool’s chief investment officer selected as the top pick for 2014 in our free report!
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×